Mclean Hospital clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-20
What changed in the last 30 days
5 trials changed in the last 30 days: 0 stopped, 4 with notable changes, 1 with a minor change only.
- Minor: Magnesium Vitamin B6 in First Episode Bipolar Disorder Trial completed
- Notable: ELS · Life Stress and Depression: Molecular and Functional Imaging Primary and study completion pushed from Jun 30, 2026 to Apr 30, 2027
- Notable: Pharmaco-Neuroimaging Studies of Approach/Avoidance Behaviors and Post-Mortem Studies: Study 1.2 (Stress Manipulation) Primary and study completion pushed from Jun 30, 2026 to Apr 30, 2027
- Notable: Synaptic Mechanisms of Intermittent Theta Burst Stimulation for Major Depressive Disorder Recruitment opened
- Notable: SPARC-LI · Day of Ultra-accelerated TMS With a Single Dose of NRX-101 Recruitment opened
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
Active trials by phase
| Early Phase 1 | 4 | |
| Phase 1 | 1 | |
| Phase 1/2 | 2 | |
| Phase 2 | 4 | |
| Phase 2/3 | 1 |
Not charted: 26 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Disease areas by active trials
Depression (14) · Anxiety (8) · Bipolar Disorder (6) · Schizophrenia (4) · PTSD (3) · Alzheimer's Disease (2) · Dementia (2)
Get alerts when Mclean Hospital's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.